Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Erivedge Approved to Treat Basal Cell Carinoma
MONDAY, Jan. 30 (HealthDay News) -- Erivedge (vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cell carcinoma, the agency said Monday.
Not Enough Americans Being Screened for Cancer
THURSDAY, Jan. 26 (HealthDay News) -- U.S. residents are not being screened for cancer at the recommended levels, and screening rates vary by several demographic factors, according to research published in the Jan. 27 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.
Unemployed Have Poorer Mental and Physical Health
TUESDAY, Jan. 24 (HealthDay News) -- Unemployed adults are about half as likely to have health insurance as employed individuals; have poorer mental and physical health, regardless of their insurance status; and are less likely to receive needed medical care and prescriptions, according to a January data brief issued by the National Center for Health Statistics.
No Mitotic Difference in Single or Multiple Primary Melanomas
MONDAY, Jan. 23 (HealthDay News) -- For patients with single primary melanoma (SPM) and multiple primary melanomas (MPM), there is no significant difference in the presence or absence of mitosis, according to a study published online Jan. 13 in Cancer.
Many Tweens Don't Follow Correct Sun Behaviors
MONDAY, Jan. 23 (HealthDay News) -- At least half of 10 year olds report experiencing sunburn in the past year and, as they hit their teen years, they report spending more unprotected time in the sun to get a tan, according to a study published online Jan. 23 in Pediatrics.
Positive Patch Test Reaction Rates Similar for Elderly, Adults
FRIDAY, Jan. 20 (HealthDay News) -- Approximately two-thirds of older individuals have at least one positive patch test reaction to contact allergens, similar to the rates for adults and significantly increased compared with the rates for children, according to a study published in the February issue of the Journal of the American Academy of Dermatology.
Long-Term Adalimumab Safe, Effective for Psoriasis
FRIDAY, Jan. 20 (HealthDay News) -- The long-term efficacy of adalimumab is well maintained in patients who experience an initial response of 75 percent or greater improvement in the Psoriasis Area and Severity Index score (PASI 75), according to a study published in the February issue of the Journal of the American Academy of Dermatology.
BRAF + MEK Inhibitor May Help Avoid Cutaneous Carcinomas
WEDNESDAY, Jan. 18 (HealthDay News) -- Combining the BRAF inhibitor vemurafenib with an MEK inhibitor may help prevent squamous-cell carcinomas in melanoma treatment, according to a study published in the Jan. 19 issue of the New England Journal of Medicine.
Excess Weight Found to Double the Odds of Acne in Teen Girls
TUESDAY, Jan. 17 (HealthDay News) -- Overweight and obese girls are twice as likely to have moderate to severe acne, but this is not the case for overweight boys, according to a study published in the January issue of the Archives of Dermatology.
U.S. Health Care Expenditure Still Unevenly Distributed
FRIDAY, Jan. 13 (HealthDay News) -- Health care expenditure in the United States is still unevenly distributed, with 1 percent of the population accounting for approximately 20 percent of expenditure in 2008 and 2009, according to a January statistical brief published by the Agency for Healthcare Research and Quality (AHRQ).
Erectile Dysfunction Linked to Previous Psoriasis Diagnosis
THURSDAY, Jan. 12 (HealthDay News) -- Erectile dysfunction (ED) is associated with a previous diagnosis of psoriasis, according to a study published in the January issue of The Journal of Sexual Medicine.
Antiestrogens May Counter Increased Skin Cancer Risk
MONDAY, Jan. 9 (HealthDay News) -- For breast cancer patients receiving antiestrogen therapy, there doesn't appear to be an excess risk of secondary cutaneous melanoma, according to a study published in the January issue of Cancer Prevention Research.
Cancer-Related Mortality Continues to Decrease
WEDNESDAY, Jan. 4 (HealthDay News) -- Overall cancer rates have decreased for men and remained stable for women, but mortality from cancer has declined for both men and women, according to a report from the American Cancer Society published online Jan. 4 in CA: A Cancer Journal for Clinicians.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: January 2012 Briefing - Cardiology||Next: January 2012 Briefing - Diabetes & Endocrinology|
Reader comments on this article are listed below. Review our comments policy.